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a b s t r a c t
Hyperpolarised gas lung MRI using xenon-129 can provide detailed 3D images of the ventilated lung air-
spaces, and can be applied to quantify lung microstructure and detailed aspects of lung function such as
gas exchange. It is sensitive to functional and structural changes in early lung disease and can be used in
longitudinal studies of disease progression and therapy response. The ability of 129Xe to dissolve into the
blood stream and its chemical shift sensitivity to its local environment allow monitoring of gas exchange
in the lungs, perfusion of the brain and kidneys, and blood oxygenation. This article reviews the methods
and applications of in vivo 129Xe MR in humans, with a focus on the physics of polarisation by optical
pumping, radiofrequency coil and pulse sequence design, and the in vivo applications of 129Xe MRI and
MRS to examine lung ventilation, microstructure and gas exchange, blood oxygenation, and perfusion
of the brain and kidneys.
 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
The noble gas xenon was discovered in 1898 by William Ram-
say and Morris Travers, and named from the Greek for ‘‘stranger”
[1]. Of the nine naturally occurring isotopes of xenon, only 131Xe
and 129Xe have non-zero spin, which permits magnetic resonance.
131Xe has spin 3/2 and a nuclear electric quadrupole moment
(which dominates spin-lattice relaxation, shortening T1 to millisec-
onds), while 129Xe has spin 1/2, no quadrupole moment and a gyro-
magnetic ratio 3.4 times larger than 131Xe [2]. Xenon is an
excellent probe of its chemical environment because it is inert
and monatomic with a large spherical electron cloud, the distortion
of which affects the NMR chemical shift [3], and 129Xe MR spec-
troscopy has been employed as such in many studies to determine
the properties of a diverse range of microporous solids [2,3].
Laser optical pumping, where circularly polarised light of a suit-
able wavelength is used to drive the electron spins of certain atoms
into non-Boltzmann energy level distributions, was discovered by
Kastler in 1950 [4]. In 1960, Bouchiat et al. from the same institute,
ENS in Paris, showed that angular momentum could be transferred
from the electron spins of optically pumped rubidium vapour to
the nuclear spins of 3He gas [5], the first demonstration of spin-
exchange optical pumping (SEOP, see Section 2). The first applica-
tion of SEOP to 129Xe was demonstrated in 1978 [6] and the tech-
nique was further developed by the Happer group at Princeton
[7,8], which eventually led to hyperpolarised 129Xe NMR spec-
troscopy [9] and the first biomedical imaging studies in the
1990s. In 1994 Albert et al. presented the first MR images of hyper-
polarised 129Xe in excised mouse lungs [10]. The potential of MR
imaging of 129Xe in both its gas-phase and dissolved-phase in the
lungs, and subsequent uptake in to the circulatory system, brain
and other organs was recognised in the first publications on the
subject [10–12]. The first in vivo hyperpolarised gas MR images
of human lungs were demonstrated by Ebert et al. [13] and MacFall
et al. [14] in 1996 using 3He, and Mugler et al. in 1997 using 129Xe,
along with 129Xe spectra of the chest and head [11]. We now per-
form 129Xe MRI routinely in patients for clinical investigations of
lung disease [15].
The noble gases 3He and 129Xe are particularly suitable as
inhaled contrast agents for MR imaging. Noble gases are character-
istically safe, non-toxic and unreactive. The 3He and 129Xe isotopes
have a nuclear spin of 1/2, yielding a two-state nuclear energy level
structure in the presence of a magnetic field. Crucially, their
nuclear polarisations can be dramatically increased using SEOP,
facilitating MR signal enhancements of up to 4–5 orders of magni-
tude. The gyromagnetic ratios of 3He and 129Xe, pertaining to the
available MR signal, are roughly 75% and 25% that of 1H respec-
tively (Table 1). Helium is almost completely insoluble in the lung
parenchyma [16] and blood [17] (Ostwald solubility coefficient < 0.
01) due to its tightly bound electron cloud. In contrast, the large,
polarisable electron cloud of xenon allows it to dissolve in
parenchymal tissue, blood plasma and red blood cells (Ostwald sol-
ubility coefficients are: ~0.1 [18], ~0.09 [19] and ~0.2 [19] respec-
tively). It is this non-negligible solubility that permits uptake of
xenon into the bloodstream and the subsequent inhibition of N-
methyl-D-aspartate receptors in the neuronal cells that is believed
to lead to the anaesthetic function of xenon gas [20]. Despite this
effect, MR imaging of inhaled 129Xe is safe and well-tolerated in
healthy volunteers and patients with pulmonary disease [21,22],
including children as young as 6 years old [23]; the 129Xe dose is
1 L or less and breath-holds are short (usually < 16 s) and thus
the alveolar concentration is well below the minimum alveolar
concentration required to induce anaesthesia. Since the xenon
electron cloud is easily distorted, the local magnetic field at the site
of the nucleus is readily altered in different chemical environ-
ments. As a result, 129Xe displays a broad range of NMR chemical
shift values; of the order of hundreds of ppm when dissolved in
various liquids and biological tissues [24].
Due to the higher gyromagnetic ratio and relative ease of polar-
isation [12], 3He has historically been the focus of hyperpolarised
gas lung MRI research until recently [25,26]. However, the 3He iso-
tope is rare (being only produced during tritium decay in the
nuclear industry) and in recent years has become increasingly
scarce and expensive [21,27]. Xenon occurs naturally in the atmo-
sphere in small concentrations (87 ppb), 26.44% of which is consti-
tuted by the 129Xe isotope. After extraction from the air via
liquefaction and gas separation, xenon gas can be isotopically
enriched to increase the 129Xe fraction up to 80–90%. The availabil-
ity of 129Xe, coupled with progress in 129Xe polarisation and imag-
ing technology, has motivated a shift towards 129Xe for imaging the
airspaces of the lungs, and renewed interest in utilising 129Xe for
the investigation of gas exchange, lung perfusion, blood oxygena-
tion, and gas uptake in the brain and kidneys.
Hundreds of millions of people worldwide suffer from chronic
respiratory diseases including asthma, chronic obstructive pul-
monary disease (COPD), cystic fibrosis (CF) and interstitial lung
disease (ILD) [28]. Pulmonary function tests are the clinical stan-
dard for assessment of lung disease but they only provide global
metrics about the function of the lungs as a whole, and are insen-
sitive to early-stage lung disease and subtle changes in lung func-
tion. Sensitive, repeatable measures that provide regional
information about lung structure and function are essential for
the early detection and thorough assessment of spatially heteroge-
neous lung diseases. High resolution computed tomography (CT) is
the gold standard for structural imaging of the lungs; however, it
does not provide functional information and entails a significant
radiation dose [29], which is a particular problem in high risk
patient groups such as pregnant women and children, and in dis-
eases such as CF where longitudinal monitoring is necessary [30].
Ventilation-perfusion scintigraphy and single photon emission
tomography (SPECT) are used clinically to image lung ventilation
and perfusion function, yet they suffer from poor spatial resolution
and the risks of ionising radiation.
Proton (1H) MRI of the lungs is limited by the low proton den-
sity of the lung parenchyma and signal loss due to the magnetic
susceptibility differences between the numerous air-tissue inter-
faces (short T2* [31]), with respiratory and cardiac motion present-
ing additional challenges [32,33]. Advances in scanner hardware
Table 1
Properties of 1H, 3He and 129Xe.
Properties 1H 3He 129Xe
Isotope abundance (%)a 99.99 1.37  104 26.44
Nuclear spina ½ ½ ½
Gyromagnetic ratio (MHz/T)a 42.58 32.43 11.78
Spin density (1019 atoms/cm3)b 6690 2.37 2.37
Chemical shift range (ppm)c ~10 ~0.8 ~250
Self-diffusion coefficient (cm2/s)d,e 2  105 2.05 0.062
Free diffusion coefficient (in air)
(cm2/s)e
– 0.86 0.14








a From Ref. [300].
b From Ref. [301], 1H spin density in water, gas spin densities at 1 atm and 37 C.
c From Refs. [24,302], chemical shift offset from gaseous phase resonance
(0 ppm).
d From Ref. [303], self-diffusion coefficient of water at 25 C.
e From Ref. [176], assuming gas at 1 atm and 37 C, and an air mixture of 79% N2
and 21% O2.
f From Ref. [18], for gas at 1 atm and 37 C.
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and pulse sequence design have enabled the assessment of lung
morphology (structure) with 1H MRI [32], for example using
ultra-short echo-time (UTE) sequences [34,35], which can provide
an alternative to CT in some situations [35,36]. Functional lung
images can be obtained with 1H MRI [37] either by using external
contrast agents which alter T1 relaxation times, as with dynamic
contrast enhanced perfusion imaging [38] and oxygen-enhanced
imaging [39], or by using the modulation of the proton signal
caused by respiratory and cardiac motion to infer lung ventilation
and perfusion indirectly [40]. While these techniques offer the
advantage of functional imaging without the need for additional
hardware, hyperpolarised gas MRI allows direct imaging of the
inhaled contrast agent and can be tuned to different aspects of lung
function, and also probe more distal organs in the case of hyperpo-
larised 129Xe MRI.
This review will focus on the methodology and applications of
hyperpolarised 129Xe MRI and MRS, covering: 1. optical pumping
physics, 2. imaging physics considerations, 3. radiofrequency coils,
4. ventilation imaging, 5. diffusion-weighted imaging and mod-
elling, 6. dissolved-phase 129Xe lung MRI and MRS, 7. 129Xe dis-
solved in human blood, and 8. imaging inhaled 129Xe beyond the
lungs.
2. Spin-exchange optical pumping physics
While it is possible to perform MR imaging on thermally polar-
ized (i.e. non-hyperpolarised) 129Xe (for example in high-pressure
cells for the purpose of quality control testing), the low density
of gases compared to protons in water and biological tissue renders
the NMR signal of this non-hyperpolarised 129Xe too low for in vivo
lung imaging in practice. To overcome this inherent sensitivity lim-
itation, the nuclear spin polarisation of 129Xe can be enhanced
beyond its thermal equilibrium Boltzmann polarisation, resulting
in a ‘‘hyperpolarised” (HP) 129Xe nuclear spin system.
Although HP 129Xe can be produced by dynamic nuclear polar-
isation [41], the technique most commonly used to hyperpolarise
129Xe nuclei for MR applications is rubidium (Rb) spin-exchange
optical pumping (SEOP) [6,8]. SEOP is a two-step physical process
involving (i) polarisation of the valence electrons in Rb vapor
through absorption of circularly polarised light (optical pumping)
and (ii) collisional energy transfer from the polarised Rb electrons
to 129Xe nuclei (spin exchange) – see Fig. 1. SEOP with 129Xe gen-
erally requires relatively low densities of xenon gas (0.01–0.25
xenon partial pressure) owing to high destruction rates of Rb elec-
tron polarisation at elevated xenon concentrations [42]. The gas
mixture used for 129Xe-SEOP is therefore diluted with a buffer
gas – typically either a 4He-N2 mixture or pure N2 gas – which also
serves to (i) prevent emission of non-circularly polarised photons
during electronic Rb relaxation [43]1; and (ii) pressure broaden
the Rb D1 linewidth, which improves photon absorption efficiency
[44].
Typically, one of two approaches to produce HP 129Xe with SEOP
is used: the ‘‘stopped- flow (SF)” (also known as ‘‘batch”) mode
[45–47,309], in which higher-density xenon gas mixtures (up to
25% xenon concentration) are dispensed directly from the SEOP
cell; and (ii) the ‘‘continuous-flow (CF)” mode [48–54], in which
a lower-density xenon gas mixture (1–3% xenon concentrations)
is allowed to flow through the SEOP cell over a period of time,
and xenon is cryogenically separated from the buffer gases. While
higher 129Xe polarisation values have been reported in SF-SEOP
[46,47,55,56], the xenon production rates are generally of the order
of 100 mL/h, with the highest observed being ~1000 mL/h [56],
which can be compared to >1000 mL/h characteristic of CF-SEOP
[48,49,51]. There is therefore a trade-off between the achievable
129Xe polarisation and the xenon volume production rate when
considering SF- and CF-SEOP methods for a given application. For
example, for MR applications of HP 129Xe in a clinical setting,
CF-SEOP is most suitable, as it is critical to have a large volume
production rate in order to enable large volumes of 129Xe to be
produced on demand; whereas for applications where
high-throughput and large volumes of xenon are not required
(e.g. in vitro NMR 129Xe applications), SF-SEOP is more suitable.
A useful metric to evaluate 129Xe polariser performance is the
dose equivalent rate, DErate = fQXePXe, which expresses the xenon
volume production rate (QXe) of 100% polarised
129Xe and 100%
isotopically enriched xenon, where f is the isotopic fraction of
129Xe and PXe is the
129Xe nuclear spin polarisation [58]. Through
employment and optimization of a large SEOP cell (3530 mL
volume), a high HP 129Xe production efficiency on a continuous-
flow polariser has recently been reported [59], with a
DErate of 1013 mL/h. This has enabled routine clinical lung MRI
with hyperpolarised 129Xe doses available on demand at run time
as well as high signal-to-noise ratio (SNR) 129Xe MRI of the human
brain [60–62] and kidneys [63].
3. Imaging physics considerations
The induced hyperpolarisation of 129Xe is not renewable; that
is, the polarisation relaxes by longitudinal (T1) relaxation to the
equilibrium (Boltzmann) polarisation, which is a factor of 104-
105 times lower than the induced hyperpolarisation. This decay
is accelerated when applying radiofrequency (RF) pulses. Thus,
the longitudinal magnetisation of 129Xe decays continuously from
its maximum, M0, according to RF excitation and T1, described by
the following equation, assuming a constant flip angle, h, and gra-
dient spoiling between RF pulses [64]:





where Mn is the longitudinal
129Xe magnetisation after n RF pulses
and TR is the inter-pulse repetition time.
The intrinsic gaseous T1(
129Xe) is of the order of hours at room
temperature, measured at a Xe density of 0.15 amagat [65]. How-
ever, the decay of hyperpolarised 129Xe signal in the lungs is orders
of magnitude more rapid (T1(
129Xe) approximately 20 s [66]), pri-
marily due to the presence of paramagnetic oxygen. Intermolecular
dipolar coupling between molecular oxygen and the 129Xe nuclei
leads to a linear dependence of the longitudinal relaxation rate
1/T1(
129Xe) of the gas on the partial pressure of oxygen (pO2)
[67]. The T2*(
129Xe) value in the alveoli is considerably longer than
lung T2*(
1H) values (approximately 1.4 ms at 1.5 T [31]), and is
influenced by lung inflation level (T2*(
129Xe) = 25 ms at FRC + 1 L
and 52 ms at TLC at 1.5 T) as well as B0 strength (18 ms at
FRC + 1 L and 24 ms at TLC at 3 T) [68]. As the acquired MR signal
is boosted by hyperpolarisation of the gas, image SNR is largely
independent of B0 at the current clinically-used magnetic fields
(1.5 T and 3 T) [68]; however, increased T2*(
129Xe) dephasing in
regions of B0 field inhomogeneity such as near blood vessels and
the diaphragm is evident at 3 T.
To conserve the non-renewable hyperpolarised gas signal as
much as possible, low-flip angle gradient echo and steady-state
free precession sequences form the foundation of hyperpolarised
gas pulse sequence design [64]. As the available magnetisation is
partly depolarised by each RF pulse, RF depolarisation filters are
imposed in k-space such that an image phase encoded with
sequential ordering in Cartesian space has lower SNR but higher
spatial frequency detail than an otherwise identical acquisition
1 Energy is transferred into the rotational/vibrational levels of the N2 molecules,
resulting in non-radiative electronic decay.
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using centric Cartesian phase encoding [69]. Variable flip-angle
schemes have been proposed to counteract this effect [64,70,71],
where the flip angle is stepwise increased during image acquisition
to maintain constant transverse magnetisation, but in practice
these schemes can be difficult to implement in a robust fashion
due to B1 inhomogeneity [72] and RF power limitations consider-
ing the low gyromagnetic ratio of 129Xe. Non-Cartesian k-space
acquisition trajectories lead to different RF k-space depolarisation
filters, causing artefacts and loss of spatial resolution, which can
be compensated for after signal acquisition or mitigated by using
non-sequential acquisition order to distribute the effects of the fil-
ter more evenly over k-space [73,74].
In 2D hyperpolarised gas imaging, the distribution of effective
flip angles over a realistic selected slice thickness causes the unifor-
mity of the slice profile to decrease with increasing phase encoding
number [69,72]. The smaller flip angles experienced at the edges of
the slice profile deplete the longitudinal magnetisation of 129Xe gas
at a slower rate than in the slice centre, meaning that the later
phase encodes are more heavily weighted by signal from the slice
edges. In addition, diffusion of ‘‘fresh” hyperpolarised gas from out-
side the selected slice that has not been affected by the RF pulses
adds to the in-slice signal throughout the acquisition. These effects
can cause errors in slice-selective techniques which use temporal
signal decay to calculate parameters such as the partial pressure
of oxygen in the lung (pO2) [75].
Diffusion of hyperpolarised gas within the lung airspaces during
imaging limits the achievable spatial resolution and leads to signal
attenuation resulting from the imaging gradients, reducing the
effective transverse relaxation time, though this effect is minor
compared to RF depolarisation [69] and less pronounced for 129Xe
compared to 3He due to its lower diffusion coefficient. The confin-
ing structure of healthy alveoli limits the distance that gas mole-
cules can travel but in some diseases such as emphysema the
alveolar walls are damaged or destroyed, allowing increased diffu-
sion and therefore exacerbating related effects [76]. However, the
sensitivity of hyperpolarised gas diffusion to its surrounding struc-
tural environment can be exploited as a unique means to obtain
information about lung microstructure, as addressed in Section 6.
Fig. 1. Optical pumping. (a) Simplified conceptual picture of Rb-129Xe spin-exchange optical pumping (SEOP). SEOP is a two-step process involving (i) the spin polarisation of
Rb valence electrons through optical pumping of Rb vapour with circularly polarised light resonant with the Rb D1 transition and (ii) transfer of the Rb electron polarisation to
the nuclei of 129Xe via spin-exchange collisions. The black arrows depict the polarisation of the Rb electron and 129Xe nuclear spin states. OP and SE represent optical pumping
and spin-exchange interactions, respectively. (b) Schematic of the key functional components of a continuous-flow Rb-129Xe polariser, adapted with permission from [59]. A
stopped-flow set-up is essentially the same without the need for a cryostat and magnet (see bottom right). (c) Photo of 129Xe spin-exchange optical pumping polariser located
at the POLARIS laboratory, University of Sheffield. (d) Ceramic oven containing V = 3530 mL SEOP (7.5 cm diameter, 80 cm length) cell without the lid. The pool of rubidium is
visible at the cell gas entrance (bottom of photo). Incident laser light P = 150W (BrightLock 200W, QPC, CA, USA), 794.77 nmwavelength. Gas mixture throughout: 3% Xe, 87%
He, 10% N2.
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3.1. Pulse sequences
Whilst 2D spoiled gradient echo (SPGR) scans acquired with
contiguous slices spanning the whole of the lungs are robust,
signal-to-noise benefits can be obtained with balanced steady-
state sequences that exploit the long T2 of hyperpolarised gases
by recycling the transverse magnetisation remaining at the end
of each repetition time [77,78]. However, these sequences are sen-
sitive to off-resonance effects, which can lead to banding artefacts
in regions of poor B0 homogeneity (e.g. close to the diaphragm);
these effects are more pronounced at higher field strengths [78].
SNR gains may also be realised by using 3D gradient echo acquisi-
tions in place of slice-selective 2D equivalents [79], though
increased sensitivity to motion can cause image blurring.
Non-Cartesian k-space acquisition schemes such as radial [80]
and spiral [81,82] enable time-resolved imaging of 129Xe gas with
high temporal resolution, to investigate ventilation dynamics. Spi-
ral trajectories can achieve high temporal resolution by an optimal
k-space encoding efficiency, whilst the temporal resolution of
radial encoding is maximised by sharing radial views in a sliding
window reconstruction. In addition, centre-out (ultra-short echo
time (UTE)) radial and spiral trajectories sample the centre of k-
space (k0, which is representative of the total magnetisation in
the imaging volume) every TR. Thus, the time-dependence of the
magnitude of the k0 point is intrinsically sensitive to magnetisation
dynamics; this idea can be used to correct hyperpolarised 129Xe
images for the filtering effects of RF-induced depolarisation [74].
This approach was recently extended to allow regional mapping
of the RF depolarisation (and, therefore, of the flip angles) by using
a keyhole reconstruction technique, wherein radial datasets are
divided into two temporally resolved ‘‘keys” post-acquisition
[83]. However, despite the advantages for monitoring of 129Xe
magnetisation dynamics, the SNR of 3D radial 129Xe MR images
has been reported to be lower than a dose equivalent 2D multi-
slice SPGR sequence [58]. Novel trajectories for hyperpolarised
129Xe MRI, including spiral-based techniques for efficient encoding
of 3D k-space such as Fermat Looped ORthogonally Encoded Tra-
jectories (FLORET) [84], are a subject of keen interest. 3D radial
UTE sequences show good promise for imaging of pulmonary gas
exchange with 129Xe MRI, where short T2*(
129Xe) is a limiting fac-
tor (as discussed in Sections 3.3 and 7).
3.2. Acceleration techniques
Due to the time-dependence of the magnetisation, MRI with
hyperpolarised gas is particularly suitable for image acceleration
techniques which reduce the number of RF pulses required to
acquire an image, such as parallel imaging [85,86] and compressed
sensing [87]. As fewer RF pulses are required, higher flip angles can
be used to acquire data with increased signal [88–90]. Thus, for
hyperpolarised gases, there is no SNR penalty proportional to
1/
p
R as is observed in thermally-polarised parallel imaging (where
R is the ‘‘acceleration” factor by which the number of phase encod-
ing steps is reduced compared to full Fourier encoding) [86],
enabling high acceleration factors with little degradation of the
image quality [90–93]. Compressed sensing has the advantage that
it does not require multiple receiver coils and has been successfully
implemented to accelerate 129Xe imaging and enable: acquisition
of 129Xe images and 1H anatomical MR images in a single breath-
hold which aids their registration [94]; high-resolution multiple
b-value diffusion-weighted imaging [95,96]; increased temporal
resolution in dynamic 129Xe imaging [94,97]; and combined acqui-
sition of diffusion-weighted and gas-exchange 129Xe imaging in a
single breath-hold [98]. Furthermore, prior knowledge can be used
to improve image reconstruction and achieve higher acceleration,
for instance by using knowledge of the magnetisation decay or
structural information from 1H MR images [99], or the sparsity of
complex difference images for gas flow applications [100]. As
hyperpolarised gas MR images are inherently sparse, it is possible
to simplify the reconstruction process by skipping the sparsifying
transformation step in some cases [101].
3.3. Additional considerations for MR imaging of 129Xe in the
‘‘dissolved phase”
Upon inhalation, xenon partially dissolves in the lung parenchy-
mal tissue and blood plasma (Ostwald solubility coefficient ~0.1)
and red blood cells (0.27) [102]. In the lungs, there is a distinct
downfield chemical shift of 129Xe dissolved in the lung parenchy-
mal tissue and blood plasma (referred to as TP or ‘‘barrier” by some
research groups) of 197 ppm and in the red blood cells (RBCs) of
216–222 ppm, (with respect to the resonance of gaseous-phase
129Xe in the alveolar airspace) – see Fig. 4b and Table 2. By acquir-
ing MR signals on a timescale similar to that during which 129Xe
exchanges between these compartments, the chemical shift phe-
nomenon can be exploited to quantitatively assess pulmonary
gas exchange function. This so-called ‘‘dissolved-phase” 129Xe gas
exchange MRS/MRI is a subject of active research (see Section 7).
Dissolved-phase 129Xe MRS/MRI presents several additional
challenges when compared to conventional hyperpolarised MRI
of alveolar 129Xe gas. Firstly, the complex magnetic environment
of the lungs and large susceptibility gradients between airspace
and tissue lead to extremely short transverse relaxation times of
129Xe dissolved in the lung parenchyma and blood (T2*(
129Xe) [
2 ms). Therefore, dissolved-phase 129Xe signal is usually acquired
as a free induction decay or echo with very short echo time. In light
of the benefit of longer T2*(
129Xe) values [103], considerable devel-
opment work for dissolved 129Xe MRI/MRS in humans has been
performed at a field strength of 1.5 T (T2*(
129Xe) ~2.2 ms [104]),
and this has recently been shown to be translatable to 3 T (T2*
(129Xe) ~1.1 ms) [105]. In addition, upon diffusing into the lung
parenchyma, 129Xe rapidly exchanges between the parenchyma
and pulmonary capillaries (typical time constant for airspace to
capillary transfer <100 ms [106,107]), and within the capillaries,
129Xe exchanges between plasma and RBCs on a timescale of
12 ms [108]. Dissolved phase 129Xe MRI/MRS is further compli-
cated by the low signal (~2% of that of the gaseous phase 129Xe),
which arises from the low tissue/gas volume ratio (~0.2) and low
solubility of xenon in parenchymal tissue (0.1). Fortunately, the
gaseous phase 129Xe acts as a reservoir to replenish dissolved-
phase magnetisation after its depolarisation and thus a relatively
high flip angle can be applied to the dissolved phase. This necessi-
Table 2
129Xe chemical shifts in somatic substances.
Solvent Chemical Shift (ppm)
Distilled water 190a
Saline (0.9% NaCl) 194b
Olive oil 198c
Rat adipose tissue 191d
Blood plasma 194a
197e
Erythrocytes (red blood cells) 216a
222e
Perfluorooctyl bromide emulsion (PFOB) 106f
The offset is expressed in parts per million (ppm) from the gaseous-phase 129Xe
resonance (0 ppm).
a From Ref. [304].
b From Ref. [305].
c From Ref. [24].
d From Ref. [220].
e From Ref. [223].
f From Ref. [306], PFOB is a blood substitute.
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tates careful design of RF excitation pulses to selectively excite the
dissolved phase 129Xe whilst minimising off-resonant excitation of
the gaseous phase reservoir [109,110]. Despite these challenges,
the longitudinal relaxation time of 129Xe gas in the alveolar spaces
(T1(
129Xe) ~ 25 s at 1.5 T [68]) is longer than that of a typical
breath-hold scan duration, and in blood (T1(
129Xe) ~ 6–13 s
[111–113]) is sufficient to enable detection in distal organs such
as the brain [114,115] and kidneys [63] (see Section 9).
4. Radio frequency coils
The low gyromagnetic ratio (11.78 MHz T1), unit dielectric
constant (1.00126) and nonconductive properties of gaseous
129Xe predominantly define the design considerations for radio fre-
quency (RF) coils [116]. Due to the low Larmor frequency of 129Xe
(17.66 MHz at 1.5 T and 35.33 MHz at 3.0 T) when compared to 1H
(63.83 MHz at 1.5 T and 127.6 MHz at 3.0 T), the Ohmic loss of the
RF coil is lower, as it is proportional to the square root of the res-
onant frequency (
p
x) [117]. Radiation loss is negligible as the
dimensions of the RF coil are very small when compared to the Lar-
mor wavelength, diminishing the likelihood of magnetic dipole
radiation. Dielectric losses due to capacitive coupling and dissipa-
tion due to inductive coupling with 129Xe as an NMR sample in situ
in a RF coil are nil due to the near unity dielectric constant and the
lack of conductivity [118–122], and thus, 129Xe does not contribute
to sample-dominated losses [123]. Hence, the efficiency of RF
transmission and detection for 129Xe is mainly determined by the
filling factor [124] of the RF coil. However, tissues in organs con-
taining 129Xe such as the lungs, brain and kidneys do contribute
to the sample-dominated loss by inductive coupling, which is pro-
portional to the square of the resonant frequency (x2) [120–122].
The achievable sample loss, measured as a ratio (QCoil ¼
Q Loaded  Q1Unloaded) of the quality factor with (Q Loaded) and without
(QUnloaded) the sample in situ [123], which measures coupling of
an RF coil to the sample, is proportional to Rx
3
2 þ 1 [120], where
x is the resonant frequency and R is a constant that depends on
inductive coupling and conductive losses. Although QCoil does not
provide a direct measurement of SNR, by estimating the inductive
coupling of the RF coil with the sample, it provides an indication of
the sensitivity of the RF coil to the anatomy or airspace containing
129Xe. Thus, in order to optimise a 129Xe RF coil for efficiency and
SNR, both the filling factor [124] that confirms sensitivity towards
the sample space and sample losses that confirm sample domina-
tion [123,125,126] should be optimised. In contrast, for conven-
tional RF coils for proton imaging, optimising for sample-loss
implicitly optimises filling factor as the same sample both induces
losses and generates NMR signal.
As the Larmor frequency of 129Xe is much lower than that of 1H,
receive-only RF coil arrays with a large number of channels, which
are adapted to the subject with close proximity, provide relatively
moderate improvements in SNR over transceiver RF coils [92] com-
pared to those seen for 1H receiver RF coil arrays [127,128]. Thus,
high density receiver RF coil arrays for 129Xe [93] primarily serve
the purpose of accelerating imaging by benefitting from the fact
that for hyperpolarised gases, the SNR can be preserved when
under-sampling k-space while increasing the flip angle, which is
made possible by the reduced number of RF pulses [91–93,129].
A recent approach to increase the SNR of a receiver RF coil array
for 129Xe was to optimise the filling factor and reduce conductive
loss by using superior grade copper [60].
Transmit RF coils for 129Xe lung MRI of birdcage topology are
large enough to fit an adult human torso and typically have an
elliptical or oval shape in the transverse plane orthogonal toB0 con-
forming to the patient table and magnet [93,130,131]. The design
of a non-cylindrical birdcage is determined by conformal mapping
and modal mesh currents [130,131]. Bþ1 homogeneity (i.e. standard
deviation of Bþ1 field amplitude) of 7% is achievable, which may be
compared to 16% achieved with a flexible dual Helmholtz coil
[130]. However, the latter has advantages in terms of comfort
and ease of patients’ entry into the magnet. In contrast, transmit
RF coils of birdcage topology for 129Xe brain MR imaging have a
cylindrical shape with Bþ1 homogeneity of 6.5% [60,114].
In clinical practice, it is often necessary to acquire spatially con-
cordant 1H images along with the 129Xe images, for planning,
structure-function assessment and to arrive at quantitative mea-
sures such as ventilation defect percentage [132–136]. For 129Xe
brain MRI, complementary 1H images of the brain can be acquired
in a separate session with separate RF coils, and since the human
head is rigid, the images can be easily co-registered without image
manipulation [60,114]. However, in order to co-register 1H and
129Xe images of the lungs, it is essential to acquire both image sets
in the same lung inflation state, and preferably back-to-back in the
same breath-hold, 129Xe imaging followed by 1H imaging [94,135–
138]. To achieve this the RF coil(s) can be enabled for multi-nuclear
lung imaging [139] using multi-tuned RF coils [140–143], multiple
electrically-isolated RF coils [136,144,145] or switchable-
resonance RF coils [146,147], or otherwise the scanner’s body 1H
RF coil can be used along with a dedicated RF coil for 129Xe which
is electrically isolated for 1H [132–137].
5. Ventilation imaging
MR imaging of gaseous-phase HP 129Xe during a static breath-
hold can provide detailed 3D images of the ventilated airspaces of
the lungs. Ventilation function can be quantified using several
approaches, which typically require the acquisition of co-
registered 1H anatomical images along with 129Xe ventilation
images in order to derive the total lung volume. Themost commonly
usedmetric of ventilation is the ventilation defect percentage (VDP)
– the percentage of the lung volume with low or no signal on 129Xe
ventilation MRI, and its counterpart ventilation volume percentage
(VV% = 100 – VDP) [133,148–154]. 129Xe VDP is reproducible [155–
158], increases with age [149,151,155] and correlates with pul-
monary function tests [155–157,159]. Regional 129Xe ventilation
metrics have shown significant correlation with ventilation/perfu-
sion SPECT and CT percentage emphysema [160], and CT-based sur-
rogates of lung ventilation [161]. In addition, ventilation image
signal intensity can be classified into clusters of graded ventilation
[148,150,151,154] and its regional coefficient of variation can be
calculated to assess ventilation heterogeneity [162,163].
129Xe ventilation imaging is extremely sensitive to obstructive
lung disease,2 exhibiting increased ventilation heterogeneity and
VDP in patients with chronic obstructive lung disease (COPD)
[157,159], asthma [155,163,164,311], cystic fibrosis (CF) [156,165–
167] and non-small-cell lung cancer [157], compared to healthy vol-
unteers (Fig. 2). Studies in children and young adults with CF
[156,165,167], lymphangioleiomyomatosis [168] and following allo-
genic haematopoietic stem cell transplantation [169], where ventila-
tion defects were detected in patients with clinically-normal
spirometry (i.e. indicating that 129Xe ventilation MRI is sensitive to
‘‘sub-clinical” disease), highlight the sensitivity of 129Xe ventilation
imaging to early-stage lung disease, which could allow earlier inter-
ventions to impede disease progression. In children and young adults
with CF, ventilation defects are often not associated with structural
abnormalities evident on 1Hultra-short echo timeMRI [167], suggest-
ing that early functional deficits may be detected prior to structural
damage.
2 Obstrctive lung diseases prevent patients from exhaling completely while
restrictive lung diseases cause patients to have difficulty expanding their lungs fully.
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In addition to early sensitivity, the non-ionising nature of 129Xe
ventilation MRI, coupled with its safety and tolerability in adults
and children [21–23], make it well suited for longitudinal follow-
up post-intervention scans. 129Xe ventilation MRI response to ther-
apy has been demonstrated in: patients with asthma after bron-
chodilator inhalation [163] and bronchial thermoplasty [312],
children with CF after pulmonary exacerbation and subsequent
treatment with intravenous antibiotics [170], patients with CF
after acute maximal exercise [313], patients with bronchial steno-
sis after airway stent placement [171], and a patient with adeno-
carcinoma after radiotherapy [172]. In a study monitoring
response to antibiotics in children with CF, 129Xe VDP showed
the largest relative improvement of all outcome measures [170],
and 129Xe ventilation MRI has been shown to be a sensitive method
to assess longitudinal lung disease in children and adults with CF
[158,314]. Increased 129Xe ventilation heterogeneity at low lung
inflation levels, consistent with airway closure, has been noted in
healthy elite divers who were able to exhale beyond the residual
volume of the lungs [173], and in healthy volunteers [174], empha-
sising the need to control for lung inflation level to ensure reliable
longitudinal ventilation imaging.
129Xe and 3He ventilation images of the same patient are
visually similar [157,159,161] (Fig. 2a), although greater ventila-
tion abnormalities (and quantitatively higher VDP) are often evi-
dent on 129Xe images when compared to 3He images
[157,159,163,175], likely due to the lower diffusion coefficient of
129Xe in air [176]. Similarly, the lower diffusion coefficient of
129Xe in air limits the sensitivity of time-resolved 129Xe ventilation
imaging for the detection of delayed and collateral ventilation
observed in patients with severe COPD using 3He MRI [177,178].
While 1H anatomical imaging is often performed in a separate
breath-hold, advances in multi-nuclear hardware and compressed
sensing have made imaging 129Xe and 1H within the same breath-
hold possible [94,136,138]. This provides spatially and temporally
registered images of complementary lung ventilation and
structure.
Rapid time-resolved 129Xe imaging allows visualisation of ven-
tilation and measurement of spatially resolved signal-time curves
during a breathing cycle [82,97], and velocity mapping of gas flow
in the major airways [100]. 129Xe multiple-breath washout imag-
ing, where dynamic ventilation imaging is performed over several
breathing cycles provides spatially resolved information about gas
washout complementary to the clinical multi-breath washout pul-
monary function test. This provides fully quantitative imaging of
fractional ventilation (the turnover of gas per breath), and has been
demonstrated in healthy adults [179] and a 9-year-old child with
CF [158].
6. Diffusion weighted imaging and modelling
The relatively high diffusivity of hyperpolarised noble gas iso-
topes (Table 1), in comparison to protons in water molecules, is
ideally suited for pulsed gradient echo diffusion-weighted MRI,
where the random Brownian motion of inhaled 129Xe or 3He gas
atoms in the acinar airspace is used to probe the underlying acinar
microstructure. The free diffusion coefficient (D0) of
129Xe in air (at
atmospheric pressure and body temperature) is 0.14 cm2/s [176],
and over a time-scale of several milliseconds (DÞ, 129Xe gas atoms
Fig. 2. Ventilation imaging. (a) 3He and 129Xe ventilation images of a healthy non-smoker and a patient with COPD, adapted with permission from [157]. (b) 129Xe ventilation
images of a healthy 6-year-old (HV, FEV1 = 95%) and an 11-year-old with CF (CF, FEV1 = 102%), adapted with permission from [165]. (c)
129Xe ventilation images (top) and
coefficient of variation maps (bottom; blue = low COV, red = high COV) of a patient with asthma pre- and post-bronchodilator inhalation, adapted with permission from [163].
(d) 129Xe ventilation image (left) and binning map (right; red = defect, yellow = low intensity, green = medium intensity, blue = high intensity) from an older patient with
asthma (FEV1 = 53%), adapted with permission from [155]. (In this case, ventilation defect percentage (VDP) is defined as the ratio of the number of red pixels to the total
number of pixels in the whole lung  100).
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diffuse an average distance (x







. The alveoli are the smallest
restricting structure of the lungs and have a diameter of ~0.2 mm
[180]. Thus, on a time-scale of a fewms, 129Xe atoms can encounter
the alveolar walls multiple times, restricting the diffusion and
leading to a decrease of MR signal attenuation (S) that is described
by:
S ¼ S0ebD ð2Þ
where S0 is the MR signal in the absence of diffusion and the b-value
(b) represents the diffusion-weighting applied by magnetic field
gradients. In the presence of restricting boundaries, the diffusion
coefficient (D) is called ‘‘apparent diffusion coefficient” (ADC), and
is sensitive to the underlying alveolar dimensions.
The most commonly employed method for hyperpolarised gas
diffusion-weighted MRI is a modified Stejskal and Tanner pulsed
gradient echo sequence [181] that uses two bipolar trapezoid gra-
dient pulses of equal area after RF pulse excitation. The diffusion
time (D) is defined as the interval between the middle of the first
gradient lobe and the middle of the second. Hyperpolarised gas
diffusion-weighted MRI sequences are typically implemented in
an interleaved fashion, where acquisition of each line of k-space
is repeated for each b-value, by altering the diffusion gradient
amplitude, before proceeding to the next line. This ensures that
each interleaved scan has the same TE and TR, and that motion
artefacts and signal attenuation associated with the depolarisation
by RF and T1 are minimised.
The first in vivo human 129Xe diffusion measurements were
acquired at 1.5 T in two healthy volunteers [182], where a mean
129Xe ADC of 0.040 cm2/s was obtained using two b-values of 0
and 10 s/cm2. In subsequent studies of healthy lungs across differ-
ent field strengths, similar mean 129Xe ADC values were obtained,
ranging from 0.035 to 0.050 cm2/s [157,159,183–185] (Fig. 3b).
Healthy lung 129Xe ADC values are therefore approximately 3–4
times smaller than the free diffusion coefficient of 129Xe in air,
and 5–6 times smaller than the respective 3He ADC values
(~0.2 cm2/s) in healthy lungs [186,187], reflecting the inherently
lower diffusivity of the 129Xe gas.
In a study demonstrating the clinical feasibility of 129Xe
diffusion-weighted MRI [184], 129Xe ADC values obtained in COPD
patients with emphysema (0.056 cm2/s) were significantly ele-
vated in comparison to age-matched healthy controls
(0.043 cm2/s). Other studies in COPD patients have reported global
129Xe ADC values ranging from 0.055 to 0.080 cm2/s
[153,157,159,185,315], demonstrating the sensitivity of 129Xe
ADC to emphysematous tissue destruction (shown histologically
in Fig. 3a). In these studies, the 129Xe ADC value also significantly
correlated with clinical measures of lung function, such as spirom-
etry, the transfer factor of the lung for carbon monoxide (TLCO; a
measure of gas exchange), and quantitative CT metrics of
emphysema.
Further studies have demonstrated that 129Xe ADC is elevated,
relative to younger healthy lungs, in older healthy volunteers
[184], ex-smokers [157,185,188], and in patients with idiopathic
pulmonary fibrosis [189] and lymphangioleiomyomatosis [168].
129Xe ADC measurements are highly repeatable in COPD
patients [157], and demonstrate excellent linear correlation with
3He ADC across a range of microstructural length scales
[157,159,185,315], indicating that 129Xe ADC mapping is a robust
methodology for imaging the lung microstructure. Importantly,
129Xe ADC acquired from explanted human [190] and animal
[191,192,316] lungs are significantly correlated with histologically
derived mean linear intercept (Lm), a widely accepted measure of
airspace size. Whilst the ADC value is sensitive to changes in
alveolar dimensions, the measured ADC is also dependent upon
experimental acquisition parameters such as B0 field strength
[193], and diffusion-encoding pulsed gradient strength, orientation
and timing [194–196]. As such, it is difficult to directly link ADC
measurements with lung morphometry parameters from histol-
ogy, and to compare data between different sites that were
acquired with different diffusion-weighting sequence parameters.
6.1. Theoretical models of hyperpolarised gas diffusion
The numerous airways of various sizes and orientations with
respect to the diffusion-encoding pulsed gradient contained within
each diffusion-weighted image voxel manifest as a non-Gaussian
diffusion regime with a signal behaviour that deviates from the
mono-exponential decay in Eq. (2) [197]. Theoretical models of
hyperpolarised gas diffusion have been proposed to account for
this non-Gaussian diffusion MR signal behaviour and extract mea-
surements of acinar length scales. Much work has been performed
Fig. 3. Diffusion imaging. (a) Examples of histological slides from a healthy lung
(top) and COPD lung with emphysema (bottom) that are used to calculate mean
linear intercept (Lm) measurements, adapted with permission from [307]. (b) 129Xe
ADC maps and whole lung ADC histograms for a healthy volunteer (23-year-old
female, top) and COPD patient (68-year-old male, bottom). (c) (Left) Schematic
drawing of the cylindrical model of acinar airway geometry based upon the Haefeli-
Bleuer and Weibel acinar geometry [212], adapted with permission from [308]. (c)
(Right) Cylinder model 129Xe lung morphometry maps of acinar airway radius (R)
and mean linear intercept (Lm) in the same healthy volunteer and COPD patient as
in (b). (d) (Left) Probability distributions of diffusive length scale derived from the
stretched exponential model for the same healthy volunteer and COPD patient. (d)
(Right) Stretched exponential model 129Xe lung morphometry maps of mean
diffusive length scale (LmD) for the same healthy volunteer and COPD patient.
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in modelling the effects of restricted 3He and 129Xe diffusion using
geometrical models of lung microstructure that include: cylindrical
geometries [198–201], acinar trees [202], branching structures
[203–205], alveolar ducts [203], and porous media models
[206,207]. Alternative strategies have also been proposed that do
not rely on geometrical assumptions of acinar structure: q-space
transform analysis [208,209], diffusion kurtosis [210] and
stretched exponential models [95,101,211]. To date, cylindrical
geometry [201], and stretched exponential [95] models are the
only theoretical gas diffusion models that have been used to derive
estimates of acinar length scales on a voxel-by-voxel basis from
in vivo 129Xe diffusion MRI measurements, akin to those from
obtained from histology.
The relatively small variation in acinar airway radii across the
lungs [212] forms the foundation for a model of acinar airway
geometry, known as the ‘‘cylinder” model [198,200]. In this model,
the acinar airways are modelled as infinitely long cylinders that are
covered by alveolar sleeves containing eight alveoli and are charac-
terised by two parameters, the outer acinar airway radii (R), and
alveolar sleeve depth (h) (Fig. 3c). Underpinning this acinar airway
geometry is a model of anisotropic diffusion, where more diffusion
restriction exists perpendicular to the airway axis due to the alve-
olar walls, while less restriction is observed along the airway axis
[198]. The derived longitudinal (DL) and transverse (DT) diffusion
coefficients are related to the cylindrical airway geometrical
parameters (R and h) by phenomenological expressions derived
from Monte-Carlo simulations [199–201]. Additional parameters
such as the alveolar volume (VAlv), alveolar surface area (SAlv),
and mean chord length (Lm) can then be derived based upon the
underlying cylindrical airway geometry.
An alternative theoretical model of hyperpolarised gas diffusion
signal behaviour in the lungs is the stretched exponential model, in
which in vivo estimates of alveolar length scales are derived with-
out making assumptions about the geometry of the lung
microstructure [95,101,211]. In this model, the stretched exponen-
tial function is fitted to the measured macroscopic voxel signal
attenuation that can be represented as a superposition of signals
with different apparent diffusivities (D) arising from airways with
different sizes and orientations [95]. A probability distribution of
apparent diffusivities can be estimated from the stretched expo-
Fig. 4. Probing gas exchange. (a) Cartoon of diffusive exchange of xenon gas from alveolus to capillary, via the parenchymal tissue barrier. The tissue wall thickness (air-blood
barrier thickness) is represented by d, and the total septal wall thickness separating neighbouring alveoli is represented by d. (b) 129Xe MR spectra obtained from a healthy
subject (black line) and a patient with IPF (blue line). (c) IDEAL CSI of dissolved 129Xe in the lungs of a patient with moderate COPD, illustrated in the form of ratio maps
(reproduced with permission from [104]). (d) Representative binning maps and histograms derived from Dixon-based dissolved-phase 129Xe MRI acquired from a patient
with IPF, highlighting the characteristic high TP (barrier) signal and low RBC signal compared with healthy normal subjects (dashed histogram), adapted with permission
from [251]. (The notation barrier: gas is equivalent to TP/Gas.)
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nential function parameters [213] and subsequently related to dif-
fusive length scales, representative of the distribution of micro-
scopic dimensions of the acinar airways (i.e. the diffusion-
restricting boundaries) contained within a given voxel. The shape
of this distribution is comparable to that of intercept lengths mea-
sured by histology, and can be used to derive a mean diffusion
length scale (LmD) representative of mean acinar airway dimen-
sions within a voxel (Fig. 3d).
The first in vivomeasurements of 129Xe lung morphometry were
measurements of R and Lm derived from the cylindrical model
[201] in a healthy subject and a patient with cystic fibrosis [214].
The first patient studies of in vivo 129Xe lung morphometry mea-
surements were presented in four healthy never-smokers and four
ex-smokers with COPD [215,216]. Cylindrical model anisotropic
diffusion coefficients andmorphological parameters R and Lmwere
significantly increased in COPD patients while h was reduced com-
pared with the healthy group. Further patient studies using the
stretched exponential model have demonstrated elevated 129Xe
LmD, with respect to young healthy lungs, in the lungs of ex-
smokers, and in patients with IPF and COPD [95,189].
Excellent agreement between 129Xe and 3He lung morphometry
measurements derived from the stretched exponential and cylin-
drical geometry model has been demonstrated across a range of
acinar length scales [95]. However, the validation of 129Xe lung
morphometry measurements derived from theoretical gas models
against gold standard methods for morphometry measurement
(namely, histology) has to date been restricted to preclinical stud-
ies. For example, 129Xe lung morphometry measurements from the
cylindrical geometry model were compared to histology in healthy
mice lungs [316], and in rat lungs instilled with disease models of
emphysema and radiation-induced lung injury [217–219]. Strong
correlations were observed between histologically derived mean
linear intercept and cylindrical geometry parameters. Furthermore,
good agreement (10–30 mm difference) was observed between
129Xe MR-derived Lm and mean linear intercept from histology
[218,316].
In conclusion, diffusion-weighted MR imaging with hyperpo-
larised 129Xe is a robust methodology that is sensitive to acinar air-
space size changes expressed in terms of ADC values and in vivo
lung morphometry measurements from theoretical gas diffusion
models.
7. Probing gas exchange with dissolved-phase 129Xe lung MRI
and MRS
The primary function of the lungs is to facilitate the exchange of
gases between the alveolar airspace and pulmonary capillaries.
However, there is currently a lack of robust, quantitative biomark-
ers for spatially resolved assessment of pathological gas exchange
impairment, and with sensitivity to disease progression and
response to treatment. Dissolved-phase 129Xe MRS/I – wherein
129Xe spins dissolved in the lung parenchyma and capillaries are
detected during their diffusive exchange with 129Xe gas in the alve-
oli (Fig. 4a) – may offer a solution.
7.1. Spectroscopic methods
The first in vivo HP 129Xe MR lung spectra were acquired from
rat and mouse lungs [220,221], and revealed the existence of mul-
tiple dissolved-phase 129Xe resonances, distinct from the dominant
resonance of gaseous 129Xe in the alveoli. Shortly afterwards, sim-
ilar resonances were observed in the human pulmonary system
[222], and with the aid of in vitro studies [108,223], the two
in vivo dissolved-phase 129Xe resonances – tissue and blood plasma
(TP) at ~197 ppm and red blood cells (RBCs) at 216–222 ppm –
were identified. Representative dissolved-phased 129Xe NMR
spectra obtained from the lungs of a healthy volunteer and a
patient with idiopathic pulmonary fibrosis (IPF) are shown in
Fig. 4b.
Several means to quantify pulmonary gas exchange in vivo by
MR spectroscopy with hyperpolarised 129Xe have been reported.
In the chemical shift saturation-recovery (CSSR) experiment, the
MR signal of dissolved-phase 129Xe is saturated with a selective
90 RF pulse and the subsequent signal increase due to exchange
with alveolar gaseous HP 129Xe is recorded as a function of post-
saturation delay by MR spectroscopy. It was first reported in cani-
nes that the dissolved-phase 129Xe signal as a function of delay
time shows two distinct trends: (i) an initial exponential increase
with a plateau at ~200 ms, due to the saturation of parenchymal
tissue with fresh HP 129Xe signal (i.e. related to gas exchange);
and (ii) an approximately linear increase after ~1 s [224] due to
blood flow (i.e. related to perfusion) [225]. Xenon gas exchange
can be modelled by considering two adjacent alveoli separated
by a ‘‘slab” of parenchymal tissue and capillaries (see Fig. 4a) in
order to derive metrics of pulmonary function, including alveolar
surface area to volume ratio (S/V), parenchymal septal thickness
and capillary blood flow [225–229]. The CSSR method has been
applied to assess gas exchange impairment in small animal
emphysema and human patients with COPD, revealing tissue
destruction (reduced S/V) [230,231] and alveolar septal wall thick-
ening [188,232]. In IPF patients, pronounced septal thickening has
been observed, consistent with pulmonary fibrosis [106,227].
Model-derived lung function metrics are sensitive to the lung infla-
tion level [231,232,317], and the septal thickness correlates with
the clinical standard pulmonary function test for gas exchange
(TLCO) [106,232] and was found to be repeatable in patients with
COPD [231].
Steady-state spectroscopic measurements (i.e. acquired with a
single delay time) also allow quantitative assessment of gas
exchange. The ratio of the 129Xe resonances of RBC to TP in the lung
is sensitive to thickening of the alveolar septae in IPF (Fig. 4b) and
also correlates with TLCO [233]. This approach exhibits longitudinal
sensitivity to disease progression in IPF where TLCO showed no
change [234], which has implications for disease management.
Recent efforts have been concentrated on characterisation of the
dissolved-phase 129Xe resonance lineshapes [235], accurate chem-
ical shift referencing [236] and investigating oscillations in the RBC
signal (and chemical shift) which track the cardiac cycle [237,238];
the latter is discussed further in Section 8.
7.2. Imaging methods
As pathological gas-exchange impairment is spatially heteroge-
neous, 3D spatial information is required for improved disease
management and targeted treatment in diseases such as IPF.
Simultaneous imaging of dissolved-phase and gaseous-phase
129Xe in the lung within a single read-out can be achieved by tun-
ing to the dissolved 129Xe resonance and choosing a low imaging
bandwidth to exploit the chemical shift ‘‘artefact” [109]. However,
this approach is constrained by SNR and resolution, and use of an
ultra-short echo time radial sequence with interleaved frequency
switching between dissolved-phase and gaseous-phase 129Xe
offers improved SNR performance in light of the short T2*
[239,240]. While these techniques enable imaging of dissolved
phase 129Xe (TP and RBC), distinction of the two dissolved-phase
129Xe compartments is important for quantitative gas exchange
measurements. Free induction decay (FID)-based chemical shift
imaging (CSI) with Cartesian phase encoding allows the acquisition
of spatially-resolved spectra [241], though it suffers in terms of
speed and spatial resolution. Dixon-type acquisitions [242] can
be used to separate the TP and RBC resonances by exploiting the
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phase difference between them. In particular, single-point Dixon
imaging has been developed for 129Xe gas exchange imaging;
radially-encoded images are acquired at a TE where the phase dif-
ference between TP and RBC resonances is 90 [243]. The resulting
RBC image represents 129Xe that has fully traversed the lung tissue
barrier. Compared with ‘‘multi-point” approaches, the single-point
method suffers from contamination of dissolved-phase 129Xe
images with gas-phase 129Xe signals, though a technique for
removal of this contamination has been reported [244]. An alterna-
tive approach is based on iterative decomposition with echo asym-
metric and least-squares estimation (IDEAL) [245], which involves
acquisition of images at multiple echo times to improve the sepa-
ration of gaseous, TP- and RBC-dissolved 129Xe [104]. Both radial
[104,318] and spiral [246,247] read-outs have been reported. The
single-point Dixon method is sensitive to regional gas-exchange
impairment in IPF, and dissolved-phase 129Xe MRI biomarkers
show agreement with TLCO [248,318]. Recent data demonstrate
the sensitivity of dissolved-phase 129Xe MRI to IPF disease progres-
sion [249], and distinct gas-exchange features in asthmatics and
COPD patients [104,232] and a range of cardiopulmonary patholo-
gies [250].
While IDEAL or Dixon images are typically presented as ratio
maps of RBC/TP, RBC/Gas or TP/Gas signals (see Fig. 4c), recent
efforts have been focussed on improving quantitative analysis
techniques, such as binning to create graded colour signal ratio
maps to facilitate clinical interpretation [248,251] (see Fig. 4d).
In addition, further exploration of the reproducibility of these tech-
niques is likely to aid clinical dissemination [252,253]. Recent
reports demonstrating the regional assessment of CSSR-type gas-
exchange dynamics [254,255], and novel techniques for imaging
the cardiogenic oscillations of the 129Xe RBC resonance [256],
may pave the way to maximising the obtainable functional infor-
mation about pulmonary gas exchange with hyperpolarised 129Xe.
As direct dissolved-phase 129Xe imaging techniques are ham-
pered by low SNR and short T2*, SNR benefits may be obtained
by indirect gas exchange imaging, i.e. by detection of gaseous-
phase 129Xe. The xenon polarisation transfer contrast (XTC)
method is one such indirect technique, and involves (i) gradient
echo imaging of gaseous phase 129Xe; (ii) a series of inversion/sat-
uration RF pulses centred on the dissolved 129Xe resonances (to
weight the signal intensity according to gas exchange); and (iii)
further acquisition of gaseous-phase 129Xe images [257,258]. The
regional gas depolarisation between the two images is related to
the gas exchange, can be modelled in terms of lung tissue density
and thickness [258], and correlates with histological measure-
ments of alveolar septal volume [259]. Repeating the XTC acquisi-
tion at several inter-pulse delay times (multiple exchange time
XTC (MXTC) [260,261]) permits mapping of a characteristic gas
exchange constant and has been applied to quantify tissue loss in
COPD [261]. The main limitation of XTC is that the TP and RBC res-
onances cannot be separated, since their close chemical shift and
rapid chemical exchange inhibit selective inversion.
8. 129Xe dissolved in human blood
8.1. 129Xe relaxation in human blood
The 129Xe relaxation rate in blood has been studied in previous
NMR experiments performed by several groups. In work conducted
at a field strength of 4.7 T with hyperpolarised 129Xe [111], the
spin–lattice relaxation time, T1(
129Xe), in red blood cells (RBC)
within whole blood was found to increase with blood oxygenation
(sO2), with T1(
129Xe) values of 4 s and 13 s in deoxygenated and
oxygenated blood, respectively. The same group also performed
measurements with thermally polarised 129Xe samples and found
the RBC T1(
129Xe) in deoxygenated and oxygenated blood samples
to be lower; 2.7 ± 0.22 s and 7.88 ± 0.16 s [262]. Work at a field
strength of 1.5 T [223], also reported an increase in T1(
129Xe) with
blood oxygenation (2.88 ± 0.27 s deoxygenated and 5.71 ± 0.35 s
oxygenated blood), and found the R1 = 1/ T1 to increase (or
T1(
129Xe) to decrease) non-linearly with blood oxygenation – see
Fig. 5b. Both groups found the T1(
129Xe) to be highest in blood that
had been equilibrated with carbon monoxide, which locks the hae-
moglobin molecule into a conformation similar to fully oxygenated
haemoglobin; Albert et al. [262] reported a value T1(
129Xe) = 11 ±
2 s and Tseng et al. [223] reported a value T1(
129Xe) = 7.84 ± 0.47 s.
In contrast, in a study conducted with a foam preparation of
blood, at a field strength of 4.7 T [263], the opposite dependence
of T1(
129Xe) on blood oxygenation was observed. The T1(
129Xe)
was reported to decrease from 40 s in deoxygenated blood to
20 s in oxygenated blood, and it was deduced that interactions
between xenon and paramagnetic bubbles of oxygen gas in the
blood were the principal cause of spin-lattice relaxation. The inte-
rior of the bubbles provides a residency space for gaseous xenon
and oxygen, and the bubble-walls provide a surface compartment
for the oxygen-exposed gaseous xenon in which to dissolve. Xenon
gas and paramagnetic oxygen gas in the bubbles (undergoing
nuclear-electron dipole-dipole T1(
129Xe) relaxation with a depen-
dence inversely proportional to pO2) can readily exchange with
the dissolved xenon in this regime and as such, the effect of oxygen
on T1(
129Xe) may have been overestimated.
Recently, RBC T1(
129Xe) was examined over the widest yet range
of blood oxygenations (sO2 values of 0.06–1.00) using hyperpo-
larised 129Xe [113] at a field strength of 1.5 T, where it was found
that T1 increases non-linearly with blood oxygenation [see Fig. 5b],
in agreement with the previous findings of Ref. [223]. In addition,
the authors in Ref. [113] developed a two-site (RBCs and plasma)
exchange model of the magnetization dynamics of 129Xe in whole
blood samples to determine 10 constants that underpin and
describe 129Xe NMR relaxation and exchange in isolated RBCs
and isolated plasma, as well as in whole blood samples. Four con-
stants were extrapolated by fitting the equation
1=T1 ¼ j 1 exp ðrsO2 sO2Þ
h i
þ 1=TdHb1 to the blue circle data in
Fig. 5b. Here j ¼ 4:6 106 s1 is a scaling constant, rsO2= 11.1, is
a ‘‘relaxivity index” characterizing the rate of change of 129Xe
relaxation as a function of blood oxygenation and
1=ToHb1 = 0.13 s
1 and1=TdHb1 = 0.42 s
1 are the 129Xe relaxation rates
in fully oxygenated blood and fully deoxygenated blood, respec-
tively. Two rate constants, ka = 0.022 ms
1 and kb = 0.062 ms
1,
were determined for xenon diffusing between RBCs and plasma,
respectively and two constants describing 129Xe relaxation within
isolated plasma samples were determined:rsO2 = 0.075 s
1 mM1
is the relaxivity index of 129Xe in the presence of dissolved molec-
ular O2 within plasma and1=T
0
1;b = 0.046 s
1 is the 129Xe relaxation
rate in the absence of dissolved O2. The final two constants deter-
mined from the model represent the intrinsic 129Xe-RBC relaxation
rates, 1=ToHb1;a = 0.19 s
1 and1=TdHb1;a = 0.84 s
1, in oxygenated blood
and deoxygenated blood, respectively.
Knowledge of these constants is important for future experi-
ments involving modelling of the signal dynamics of 129Xe as it
travels in the blood from lungs to distal tissues such as the brain
and kidneys.
8.2. 129Xe chemical shift in human blood
Studies at a field strength of 1.5 T have shown that the 129Xe
chemical shift in RBCs within whole blood increases non-linearly
with RBC blood oxygenation [237,264] (see Fig. 5c and d) in a sim-
ilar manner to the 129Xe relaxation dependence on blood oxygena-
tion discussed above. The 129Xe chemical shift in plasma remains
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fixed in frequency over the whole blood oxygenation range (see
Fig. 5c). Using the 129Xe-plasma resonance as a 0 ppm reference,
the 129Xe-RBC chemical shift was observed to increase from
20.5 ppm in fully deoxygenated blood to 26 ppm in fully oxy-
genated blood (Fig. 5d). This observed chemical shift vs. oxygena-
tion behaviour is consistent when the same experiment is
performed at magnetic field strengths of 1.5 T and 3 T [237], indi-
cating that it is a field-strength-independent effect.
Knowledge of tissue oxygenation can provide insight into the
pathophysiology of a variety of diseases, e.g. in the discrimination
of the penumbra following stroke [265] and identification of ische-
mia following myocardial infarction [266]. In lung diseases such as
asthma and COPD, hypoxia can influence the lifetime and the func-
tionality of neutrophils that are associated with inflammation in the
lungs [267]. The demonstrated sensitivity of the 129Xe-RBC chemical
shift to blood oxygenation [237,264] is promising as it could be used
to non-invasively probe tissue oxygenation within the lungs and
well-perfused tissues distal to the lungs. 129Xe-RBC resonance shifts
with lung oxygenation have been reported in vivo in healthy volun-
teers during breath hold [268], and in patients with IPF [233] where
a decrease in the 129Xe-RBC resonance frequency (indicating lower
oxygenation) was observed.
Norquay et al. [237] used the in vitro data of the 129Xe-RBC chem-
ical shift dependence on sO2 (Fig. 5d) as a calibration curve to deter-
mine absolute oxygenation changes in the alveolar capillary bed
during a breath-hold challenge undertaken by healthy volunteers.
For a TR of 800 ms (of the order of the RBC alveolar capillary transit
time), it was observed that the 129Xe-RBC chemical shift exhibited
a periodic modulation at the same frequency as the 129Xe-RBC sig-
nal oscillation, and with a 180 phase difference. Using the in vitro
calibration data, the sO2 in two healthy volunteers at the start of
the breath-hold was measured to be ~0.87, dropping to ~0.80 after
35 s of breath-hold apnea. The experiment was repeated for a
shorter TR of 100 ms, where both the 129Xe-RBC and 129Xe-TP sig-
nals were observed to oscillate close to the cardiac pulsation fre-
quency, in agreement with 129Xe-RBC and 129Xe-TP signal
oscillations observed in Refs. [269] and [270]. (Lower frequency
oscillations observed at TR = 800 ms are likely an alias of the
higher frequency oscillation observed for TR = 100 ms.) It was
concluded that the observed signal and chemical shift oscillations
could be attributed to changes in blood flux/oxygenation in the
capillaries during the cardiac cycle. These 129Xe-RBC cardiogenic
oscillations have recently been observed in patients with COPD,
IPF, left heart failure (LHF), and pulmonary arterial hypertension
(PAH) [238,250]. It was found that IPF patients exhibited increased
RBC amplitude and shift oscillations compared to healthy volun-
teers. Patients with COPD and PAH both exhibited decreased
RBC amplitude oscillations compared to healthy volunteers, and
interestingly LHF was distinguishable from PAH by enhanced
RBC amplitude oscillations. Thus, 129Xe-RBC cardiogenic oscillation
measurements hold promise for the distinction of functional char-
acteristics of different cardiopulmonary diseases.
Fig. 5. 129Xe dissolved in human blood. (a) Decaying spectra from 129Xe dissolved in blood acquired with inter-pulse delay = 0.5 s. The inset shows a fit performed on the
decreasing 129Xe NMR signal (integrals of 129Xe-red-blood-cell (RBC) and 129Xe-plasma absorption peaks) in order to establish 129Xe-RBC (red triangles) and 129Xe-plasma T1
values (blue squares). Here 0 ppm refers to the 129Xe gas-phase resonance frequency. The decaying spectra are from a blood sample with sO2 = 0.98. The data in (b) are the
measured 129Xe relaxation rates (1/T1) in RBCs as a function of RBC oxygenation from [237] (open blue circles) and [264] (solid black triangles). In (c) it can be seen that with
increasing oxygenation, the peak associated with 129Xe dissolved in RBCs is seen to shift measurably towards higher resonance frequency. Here 0 ppm is in reference to the
129Xe-plasma resonance frequency. Shown in (d) is a plot of the change in 129Xe-RBC chemical shift as a function of RBC oxygenation from Refs. [237] (open blue circles) and
[264] (solid black triangles).
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9. Imaging inhaled hyperpolarised 129Xe beyond the lungs
The blood supply for the brain, kidney, skeletal muscle, liver
and gastrointestinal system accounts for 80% of the cardiac output
[271]. Among these distal organs, the brain and kidney have short
arterial delivery times of ~4 s [272] and ~2 s respectively from the
lungs, short enough for inhaled HP 129Xe to retain polarisation until
delivery, enabling direct MR imaging [60,63,273,274].
129Xe dissolved in the head in vivo exhibits five distinct NMR
spectral peaks corresponding to: grey matter (196 ppm), white
matter (193 ppm), interstitial and cerebrospinal fluids (200 ppm),
soft muscular tissue (188 ppm) and red-blood cells (216 ppm)
[11,62,63,114,275,276], as seen in Fig. 6a. The NMR spectral peak
from 129Xe dissolved in the grey matter dominates the spectrum
[62,114]. With a cerebral blood flow for grey matter of 65 mL per
minute per 100 g of tissue [277], cerebral blood volume of 5 mL
per 100 g of tissue [277] and Ostwald’s grey matter to blood parti-
tion coefficient of 0.88 [278] in healthy normal individuals, the
inhaled HP 129Xe dissolved in the cerebral blood rapidly infuses
in to the grey matter tissue reaching a concentration that enables
direct MR imaging over a breath-hold of 24 s [60]. The MR image
that is obtained (Fig. 6b) is a map of uptake of inhaled gas into
the brain tissue across the intact blood-brain barrier, which is
indicative of underlying physiology such as the regional cerebral
blood flow and volume, regional mean transit time and gas transfer
rate across the blood-brain barrier [60,319]. Pre-clinical studies in
rat brains have demonstrated image contrast sensitive to sensory
stimuli [279] and induced ischemia [280]. Recently, there has been
growing interest in the potential clinical sensitivity of inhaled HP
129Xe to human brain pathology such as Alzheimer’s disease
[273] and stroke [281], as shown in Fig. 6c. HP 129Xe brain MRI
benefits from the fact that inhaled 129Xe is safe and non-invasive,
and crosses the intact blood-brain barrier, when compared to rou-
tine clinical CT and MR imaging techniques which use injected
iodine- and gadolinium-based contrast agents respectively, both
of which lead to a concern for patient safety [282–284]. In contrast
to arterial spin labelling 1H MR imaging, HP 129Xe brain MRI does
not require averaging [285], has no undesired signal from the
intra-vascular compartment [60] and the image contrast directly
depends on the underlying physiology.
In the kidneys, up to 3 spectral peaks have been demonstrated
in vivo, two of which have been assigned to red blood cells
(217 ppm) and tissue (and plasma) (198 ppm), while the origin
of the third peak at 192 ppm is yet to be determined
[274,276,286,287]. A fourth peak at ~188 ppm is believed to orig-
inate from fat tissue in the lower abdomen, outside of the kidneys.
With renal perfusion of 170 to 220 mL per minute per 100 mL of
tissue [288,289], the HP 129Xe saturates in the extra-vascular kid-
ney compartment more quickly than in the brain, although with
much lower spin density due to more rapid clearance of blood from
the kidney. Nevertheless, imaging HP 129Xe dissolved in the kidney
benefits from shorter arterial transit time, thereby less loss of
polarisation due to T1 decay in blood prior to delivery, and a fast
time-resolved acquisition can be used to characterise signal
Fig. 6. 129Xe beyond the lungs. (a) Spectrum of HP 129Xe dissolved in the human head. Spectral peaks: 189 ppm: soft muscular tissue, 193 ppm: white matter, 196 ppm: grey
matter, 200 ppm: interstitial and cerebrospinal fluids, and 217 ppm red blood cells. Brain perfusion images of (b) a healthy volunteer (adapted with permission from [60]) and
(c) a volunteer with established stroke (adapted with permission from [281]), using inhaled hyperpolarised 129Xe. (d) Kidney perfusion images of a healthy volunteer using
inhaled hyperpolarized 129Xe, adapted with permission from [63].
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dynamics [286,287]. Recent studies demonstrating MR spec-
troscopy and imaging of human kidneys in vivo using inhaled HP
129Xe [274,286,287] are encouraging, as shown in Fig. 6d.
10. Conclusions and future perspectives
129Xe lung MR is a versatile tool for the examination of lung
function and structure, providing quantitative physiological infor-
mation. Ventilation and diffusion MRI are well-established, repeat-
able techniques that are sensitive to early-stage lung disease
[157,167–169,185,188]. They have the potential to detect lung
abnormalities earlier than spirometry [168,169] and structural
imaging [167,290], allowing early intervention/therapy to mitigate
further damage. Moreover, the sensitivity of 129Xe ventilation
imaging to therapy response [158,163,171,172] coupled with its
high repeatability should enable clinical trials of novel therapeutics
with small patient numbers, as has been demonstrated with 3He
ventilation MRI [291,292]. Crucially, the lack of ionising radiation
associated with 129Xe MR is important when considering repeated
imaging, and allows safe longitudinal monitoring of disease pro-
gression and studies of therapeutic response. This and the func-
tional sensitivity of 129Xe MRI are real advantages in comparison
to CT, the clinical gold standard for lung imaging. Nevertheless,
the complementary use of 129Xe MRI alongside CT and/or advanced
1H morphological MRI allows the investigation of structure-
function relationships to gain insights into disease pathology
[167,168,293,294].
Dissolved-phase 129Xe MRS/I of the lung is still at an earlier
stage of technological development, yet shows great promise as a
probe for gas exchange. Increased signal from parenchymal lung
tissue and reduced RBC signal indicate interstitial alveolar wall
thickening and impaired gas transfer efficiency, and dissolved-
phase 129Xe techniques have demonstrated the sensitivity to dis-
tinguish healthy smokers from never-smokers [188] and to detect
longitudinal disease progression in patients with IPF earlier than
currently used clinical metrics [234,249]. During the course of
the current COVID-19 pandemic, evidence is emerging that
dissolved-phase 129Xe lung MRI is sensitive to gas exchange abnor-
malities in patients with COVID-19 [320]. The first published 129Xe
MRI study in COVID-19 patients [320], conducted after patients
had been discharged from hospital, found reduced gas-blood
exchange function and lung ventilation with normal alveolar
dimensions, while CT images showed substantial recovery com-
pared to the peak stage of COVID-19. Two patients scanned in
the acute, symptomatic phase of COVID-19 at the University of
Sheffield showed massively impaired gas exchange despite rela-
tively normal ventilation (Fig. 7), and initial results from a collab-
oration between Oxford and Sheffield Universities indicate that gas
exchange impairment is detectable using 129Xe MRI in patients
three months after being ill with COVID-19 (bbc.co.uk/news/health
-55017301). Taken together, these initial findings suggest that
dissolved-phase 129Xe lung MRI may provide a valuable tool for
the investigation of COVID-19 lung disease. The concept of a single
3D gas- and dissolved- phase 129Xe MRI acquisition for regional
assessment of gas exchange impairment and ventilation is attrac-
tive [192,250,295–297], although currently the gas-phase images
obtained from multi-resonant imaging and dedicated ventilation
images acquired separately are not interchangeable [297]. Further
development of time-efficient, repeatable gas- and dissolved-
phase imaging strategies with improved SNR may permit this in
the future. In addition, the emergence of dissolved-phase 129Xe
spectroscopy as a means to investigate blood oxygenation in vivo
[233,237,264] and detect modulations of 129Xe RBC signal and
chemical shift caused by the cardiac cycle [237,270] that differ
between patients with different cardiopulmonary disease types
[238,250] is of great clinical interest. Furthermore, evidence of
reduced gas uptake following stroke [281] and retention of inhaled
129Xe in the brain in Alzheimer’s disease [273] measured by
dissolved-phase 129Xe brain MRI are attractive to the neuroimaging
community. It is likely that the multi-faceted potential of
dissolved-phase 129Xe to probe oxygenation and gas exchange pro-
cesses in the lungs, as well as perfusion in the brain and kidneys,
will drive innovation in the field of hyperpolarised 129Xe MR in
the years to come.
With current polarisation technologies, dedicated RF coil
design and MR pulse sequence optimisation, high quality data
acquisition with progressively lower doses of enriched xenon
(86% 129Xe) and even natural abundance xenon (26% 129Xe)
[78] has been made feasible, paving the way towards low cost
129Xe MRI. Following UK Medicine and Healthcare Regulatory
Authority approval, routine clinical lung imaging has been per-
formed in Sheffield, UK since 2015 [15], a service that has
switched almost entirely to 129Xe in recent years [298]. This
important milestone establishes routine clinical 129Xe lung MRI,
opening the door to large-scale clinical evaluation of these meth-
ods in patient populations. In parallel, phase III clinical trials are
currently in progress in the U.S. to obtain Food and Drug Admin-
istration approval for hyperpolarised 129Xe as a drug-device
imaging agent [299], which should help drive international clin-
ical trials.
Fig. 7. 129Xe MRI in acute COVID-19. (a) 1H anatomical SPGR image, (b) 129Xe ventilation image and (c) 129Xe RBC/TP map acquired with an IDEAL sequence [318] of a coronal
mid-posterior slice in a patient with acute COVID-19. For this slice, ventilated volume percentage = 99.6% and RBC/TP = 0.188 (mean RBC/TP in healthy volunteers = 0.47
[318]). RBC/TP = red blood cells to tissue and blood plasma ratio.
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There is a drive towards standardisation of 129Xe MR acquisition
and analysis, to enable multi-site studies of ventilation imaging in
the first instance (cpir.cchmc.org/XeMRICTC). A thermally
polarised xenon torso phantom for quality assurance has been
developed and tested at eight sites across North America [299].
Different approaches to image segmentation for ventilated vol-
umes have been compared [152,154], and substantial inter-
reader agreement reported between blinded radiologists [164]. A
recent retrospective study of ventilation images acquired at two
institutions in children with CF found similar ventilation metrics
between sites and strong agreement between two analysts, con-
cluding that multi-centre trials in CF appear to be feasible [166].
Yet, there remains work to be done to standardise image acquisi-
tion and analysis between centres, each of which currently has
its own established workflow tuned to their situation and prefer-
ences. This is critical not only for ventilation imaging, which is
most well-developed and closest to clinical translation of the
129Xe MRI techniques, but also for diffusion-weighted 129Xe MRI
and up-and-coming techniques such as dissolved-phase 129Xe
MRS/I, to facilitate multi-site trials and aid their eventual transition
to the clinic.
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Glossary
ADC: apparent diffusion coefficient
B0: main magnetic field
B1+: transmit magnetic field
CF: cystic fibrosis
CF-SEOP: continuous flow spin exchange optical pumping
COPD: chronic obstructive pulmonary disease
CSI: chemical shift imaging
CSSR: chemical shift saturation recovery
CT: computed tomography
D: diffusivity
DDC: distributed diffusivity coefficient
DL: longitudinal diffusion coefficient
D0: free diffusion coefficient
DT: transverse diffusion coefficient
FID: free induction decay
FLORET: Fermat Looped ORthogonally Encoded Trajectories
FRC: functional residual capacity
FVC: forced vital capacity




IDEAL: iterative decomposition with echo asymmetric and least-squares estimation
ILD: interstitial lung disease
IPF: idiopathic pulmonary fibrosis
LHF: left heart failure
Lm: mean linear intercept
LmD: mean diffusion length scale
MR: magnetic resonance
MRI: magnetic resonance imaging
MRS: magnetic resonance spectroscopy
MXTC: multiple exchange time xenon polarisation transfer contrast
N2: nitrogen
NMR: nuclear magnetic resonance
PAH: pulmonary arterial hypertension
pO2: partial pressure of oxygen
Qcoil: coil quality factor
R: outer acinar airway radii
Rb: rubidium
RBC: red blood cell
RF: radiofrequency
SAlv: alveolar surface area
SEOP: spin exchange optical pumping
SF-SEOP: stopped flow spin exchange optical pumping
SNR: signal to noise ratio
sO2: blood oxygenation
SPECT: single photon emission tomography
SPGR: spoiled gradient echo
S/V: surface area to volume ratio
T1: longitudinal relaxation time
T2*: transverse relaxation time
TLC: total lung capacity
TLCO: transfer coefficient for carbon monoxide
TP: tissue-plasma
TR: repetition time
UTE: ultra short echo time
VAlv: alveolar volume
VDP: ventilation defect percentage
VV%: ventilated volume percentage
x: resonant frequency
129Xe: xenon-129
XTC: xenon polarisation transfer contrast
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